Resveratrol attenuates peripheral and brain inflammation and reduces ischemic brain injury in aged female mice

Publication date: August 2016
Source:Neurobiology of Aging, Volume 44
Author(s): Sae Im Jeong, Jin A. Shin, Sunghee Cho, Hye Won Kim, Ji Yoon Lee, Jihee Lee Kang, Eun-Mi Park
Resveratrol is known to improve metabolic dysfunction associated with obesity. Visceral obesity is a sign of aging and is considered a risk factor for ischemic stroke. In this study, we investigated the effects of resveratrol on inflammation in visceral adipose tissue and the brain and its effects on ischemic brain injury in aged female mice. Mice treated with resveratrol (0.1 mg/kg, p.o.) for 10 days showed reduced levels of interleukin-1β and tumor necrosis factor-α, as well as a reduction in the size of adipocytes in visceral adipose tissue. Resveratrol also reduced interleukin-1β and tumor necrosis factor-α protein levels and immunoglobulin G extravasation in the brain. Mice treated with resveratrol demonstrated smaller infarct size, improved neurological function, and blunted peripheral inflammation at 3 days postischemic stroke. These results showed that resveratrol counteracted inflammation in visceral adipose tissue and in the brain and reduced stroke-induced brain injury and peripheral inflammation in aged female mice. Therefore, resveratrol administration can be a valuable strategy for the prevention of age-associated and disease-provoked inflammation in postmenopausal women.

Graphical abstract

from #ORL via xlomafota13 on Inoreader http://ift.tt/1U2Tpk1
via IFTTT